Mangalam Organics Q2: PAT flat YoY at ₹3.36 Cr, adjusted profit down ~50% on margins
PAT +4.52% YoY · revenue +78.02% · margins compressing
₹281.46 Cr
+78.02% YoY
₹3.36 Cr
+4.52% YoY
1.19%
-0.6pp YoY
₹3.74
Mangalam Organics' consolidated revenue jumped 78.0% YoY to ₹281.46 Cr (from ₹158.10 Cr in Q2 FY26) and 57.2% QoQ (from ₹179.09 Cr in Q1 FY27) — its strongest topline quarter in this run. Consolidated PAT, however, was effectively flat YoY at ₹3.36 Cr (+4.5% from ₹3.21 Cr) and fell 53.8% QoQ from ₹7.27 Cr. That YoY comparison is flattered by a weak prior-year base: Q2 FY26 carried a ₹3.51 Cr one-off exceptional loss that pulled that quarter's PBT down from ₹7.68 Cr to ₹4.18 Cr. Stripping that out, adjusted YoY PAT growth is roughly -50% (₹3.36 Cr versus an adjusted ~₹6.72 Cr) — revenue growth has not come close to translating into profit growth this quarter.
Q2 FY-2027 vs prior quarters
The gap sits mostly in costs: cost of materials consumed rose to 70.9% of revenue, up from 63.0% a year ago and 68.6% last quarter, compressing net margin to 1.19% from 1.80% YoY and 4.06% QoQ. Operating margin (EBITDA/revenue) did improve YoY, turning positive at 7.66% versus -2.05% in Q2 FY26, but that was still a step down from 12.40% in Q1 FY27 — and combined finance cost plus depreciation rose 25.9% YoY to ₹16.60 Cr as consolidated borrowings climbed to ₹377.4 Cr (from ₹356.2 Cr at March 2026), eating into the operating-level gain before it reached the bottom line. Standalone PAT was just ₹0.88 Cr, underlining that most of the group's profit this quarter came from the three subsidiaries (Mangalam Brands, Mangalam Pooja Stores, Mangalam Speciality Chemicals) rather than the parent. There is no analyst coverage or consensus estimate on record for this stock, and the company has issued no formal guidance, so this print cannot be benchmarked against a prior outlook; no management press release accompanied the filing beyond the board-meeting outcome, which separately covered the appointment of Vaibhav Gandhi as an additional independent director and disclosed a promoter-group pledge of 11.36 lakh shares days before results.
The stock went into the print at ₹446.25, up 7.4% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Consolidated EPS ₹3.74 for the quarter, essentially flat vs ₹3.73 a year ago and well below ₹8.49 in Q1 FY27.
W1
Whether the material cost ratio (70.9% of revenue this quarter) eases back toward the 63-69% range seen in the prior two quarters.
W2
Finance-cost trajectory given consolidated borrowings rose to ₹377.4 Cr (Sep'26) from ₹356.2 Cr (Mar'26) — watch Q3 interest expense.
W3
Whether the 78% YoY revenue surge sustains into Q3, since PAT did not scale with it this quarter.
PAT is PBT-minus-tax before OCI (matches prior-quarter convention in context); consolidated OCI of -₹0.15 Cr this quarter gives Total Comprehensive Income of ₹3.20 Cr. Year-ago quarter (Q2 FY26) carried a ₹3.51 Cr one-off exceptional loss that this quarter does not; adjusted YoY growth strips that out. Both statements clearly typed/legible.